Delivery Order SPE2DB22D2007-SPE2DB24FH9VF
Award Date 2/21/24
Potential Completion Date 3/13/24
Potential Value $8.1K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $48,621.84 to provide VYVGART 400 MG/20 ML VIAL 20ML pharmaceutical products. This contract has a completion date of March 12, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this award. This delivery order contract is issued under a larger indefinite delivery contract (IDC)...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $23,976.78 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) for 400 mg/20 ml vials of the pharmaceutical product VYVGART. This delivery order has a completion date of November 17, 2023. Amerisourcebergen Drug Corp serves as a prime contractor providing pharmaceutical products and medical supplies to U.S. government agencies, including the Department of Defense. The company...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a division of Amerisourcebergen Corporation, for the supply of VYVGART 400 MG/20 ML VIAL 20ML pharmaceutical products. The contract has a potential value of $16,207.28 and a completion date of February 23, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this award and serves as a supplier of pharmaceuticals and medical supplies to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract has a potential value of $8,103.66 and a completion date of March 25, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of up to...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $25,585.02 delivery order by the Defense Logistics Agency on November 7, 2025, for VYVGART 400 mg/20 ml vials. The contract represents a firm fixed price delivery order with an ultimate completion date of December 2, 2025, and was competitively awarded without set-aside designation. This award is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the provision of VYVGART 400 MG/20 ML VIAL 20ML. The contract has a ceiling value of $8,528.34 and is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency, a defense agency. The contract has an ultimate completion date of July 30, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the Defense...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $47,953.56 firm fixed price delivery order contract by the Defense Logistics Agency to provide VYVGART 400 MG/20 ML vials. The contract has no set-aside designation. Performance will occur in Conshohocken, Pennsylvania with all items to be delivered by November 14, 2023. The Defense Logistics Agency utilizes contracts such as this to efficiently procure necessary pharmaceuticals and medical...
- Amerisourcebergen Drug Corp has received a $7,992.26 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply VYVGART 400 MG/20 ML VIAL 20ML pharmaceutical products. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania by December 2023. As a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical sourcing and distribution services company, Amerisourcebergen Drug Corp regularly provides...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $16,207.28 firm fixed price delivery order is for the supply of VYVGART 400 MG/20 ML VIAL 20ML, a pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) issued by DLA to Amerisourcebergen Drug Corp, with a potential value of...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical with a potential value of $2,690.10. The contract, which has no set-aside designation, requires the delivery of pharmaceutical products and medical supplies to support U.S. military treatment programs and facilities. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA with a...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FH9VFDelivery Order
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide VYVGART 400 MG/20 ML VIAL 20ML, a pharmaceutical product, with a potential value of $8,103.66. The contract has a completion date of March 13, 2024. Amerisourcebergen Drug Corp has also been awarded an Indefinite Delivery Contract (IDC) by DLA to provide a comprehensive range of pharmaceutical products and medical supplies to military treatment programs and facilities, with a potential value of up to $999,999,999.00 through December 31, 2025. The contract does not have a set-aside designation.
Generated 5/22/24, 11:22 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.1k | 2/21/24 |